| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 540 | 2022 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 471 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 392 | 2022 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 120 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 100 | 2022 |
| The effect of climate change and the snail-schistosome cycle in transmission and bio-control of schistosomiasis in Sub-Saharan Africa TA Adekiya, RT Aruleba, BE Oyinloye, KO Okosun, AP Kappo International journal of environmental research and public health 17 (1), 181, 2020 | 78 | 2020 |
| Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer RT Aruleba, TA Adekiya, BE Oyinloye, AP Kappo International journal of molecular sciences 19 (2), 386, 2018 | 62 | 2018 |
| Structure-based docking studies of GLUT4 towards exploring selected phytochemicals from Solanum xanthocarpum as a therapeutic target for the treatment of cancer BE Oyinloye, TA Adekiya, RT Aruleba, OA Ojo, BO Ajiboye Current drug discovery technologies 16 (4), 406-416, 2019 | 36 | 2019 |
| PZQ therapy: how close are we in the development of effective alternative anti-schistosomal drugs? RT Aruleba, TA Adekiya, BE Oyinloye, P Masamba, LS Mbatha, ... Infectious Disorders-Drug Targets (Formerly Current Drug Targets-Infectious …, 2019 | 35 | 2019 |
| Inhibitory potential of repurposed drugs against the SARS-CoV-2 main protease: a computational-aided approach AO Fadaka, RT Aruleba, NRS Sibuyi, A Klein, AM Madiehe, M Meyer Journal of Biomolecular Structure and Dynamics 40 (8), 3416-3427, 2022 | 29 | 2022 |
| COVID-19 diagnosis: A review of rapid antigen, RT-PCR and artificial intelligence methods RT Aruleba, TA Adekiya, N Ayawei, G Obaido, K Aruleba, ID Mienye, ... Bioengineering 9 (4), 153, 2022 | 29 | 2022 |
| Applications of computational methods in biomedical breast cancer imaging diagnostics: a review K Aruleba, G Obaido, B Ogbuokiri, AO Fadaka, A Klein, TA Adekiya, ... Journal of Imaging 6 (10), 105, 2020 | 27 | 2020 |
| Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation OA Ojo, RT Aruleba, TA Adekiya, NRS Sibuyi, AB Ojo, BO Ajiboye, ... Journal of Biomolecular Structure and Dynamics 40 (2), 848-859, 2022 | 24 | 2022 |
| Structural analysis and epitope prediction of MHC class-1-chain related protein-a for cancer vaccine development TA Adekiya, RT Aruleba, S Khanyile, P Masamba, BE Oyinloye, AP Kappo Vaccines 6 (1), 1, 2017 | 23 | 2017 |
| In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis TA Adekiya, RT Aruleba, A Klein, AO Fadaka Journal of Biomolecular Structure and Dynamics 40 (8), 3697-3705, 2022 | 22 | 2022 |
| The practicality of the use of liquid biopsy in early diagnosis and treatment monitoring of oral cancer in resource-limited settings HA Adeola, IO Bello, RT Aruleba, NM Francisco, TA Adekiya, AO Adefuye, ... Cancers 14 (5), 1139, 2022 | 22 | 2022 |
| Can we harness immune responses to improve drug treatment in leishmaniasis? RT Aruleba, KC Carter, F Brombacher, R Hurdayal Microorganisms 8 (7), 1069, 2020 | 22 | 2020 |
| Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and … OA Ojo, AA Afon, AB Ojo, BO Ajiboye, MA Okesola, RT Aruleba, ... Journal of food biochemistry 43 (3), e12772, 2019 | 22 | 2019 |
| Anti-hypercholesterolemic effect of unripe Musa paradisiaca products on hypercholesterolemia-induced rats TA Adekiya, SA Shodehinde, RT Aruleba Journal of Applied Pharmaceutical Science 8 (10), 090-097, 2018 | 22 | 2018 |
| Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 HY Wunrow, RG Bender, A Vongpradith, SB Sirota, LR Swetschinski, ... The Lancet Neurology 22 (8), 685-711, 2023 | 18 | 2023 |
Tayo Alex Adekiya, Ph.DHoward UniversityVerified email at howard.edu
